logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Pilar García-Alfonso

general university gregorio maranon hospital
H指数:35
被引数:6,812

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

更正：高血压作为贝伐珠单抗含药一线疗法在转移性乳腺癌和结直肠癌中的预测因素（BRECOL [GEICAM/2011-04] 研究）。

Clinical and Translational Oncology
IF2.5
2025-11-250
OAAI
Álvaro Rodríguez-Lescure; Javier Gallego; Pilar Garcia-Alfonso; Bartomeu Massuti; Raúl Márquez; Lourdes Calvo; Pedro Sánchez-Rovira; Antonio Antón; José Ignacio Chacón; Eva Ciruelos; Jose Juan Ponce; Ana Santaballa; Manuel Valladares-Ayerbes; María Rosario Dueñas; Vicente Alonso; Jorge Aparicio; Sara Encinas; Luis Robles; María José Escudero; Rosalía Caballero; Susana Bezares; María Victoria García-Ortiz; Teresa Morales-Ruiz; Juan de la Haba-Rodriguez
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study

液体活检-实体瘤治疗反应评价标准（LB-RECIST）在转移性结直肠癌（mCRC）患者中的临床验证：PLATFORM-B研究的结果

ESMO Open
IF8.3
2025-09-030
OAAI
V. Martelli; J. Vidal; J. Gibert; M.C. Fernández-Rodríguez; J. Linares; P. García-Alfonso; D. Páez; V. Alonso; M.A. Gomez-España; M. Guix; C. Santos; G. Duran; E. Élez; R. Garcia-Carbonero; R. Ferreiro; E. Pineda; J. Sastre; M.T. Cano; J.L. Manzano; F. Losa; E. Aranda; F. Rivera; A. Sibilio; R. Toledo; J. Tabernero; R. Salazar; B. Bellosillo; C. Montagut
Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients

循环hsa-miR-29c-3p和VEGF-A水平预测老年转移性结直肠癌患者对FOLFIRI联合阿柏西普的治疗反应

European Journal of Clinical Investigation
IF3.6
2025-08-010
OA
Marta Toledano-Fonseca; María Teresa Cano-Osuna; Elena Élez; Javier Soto-Alsar; David Páez; Ana Fernández-Montes; Begoña Graña; Antonieta Salud; Alfonso Yubero; Ismael Macías; Guillermo Quintero; Carlos López-López; Teresa Fernández-Rodríguez; María Victoria García-Ortiz; Javier Sastre; Pilar García-Alfonso; Antonio Rodríguez-Ariza; Enrique Aranda; the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer
BMC CANCER
IF3.4
2025-04-210
OAAI
Valladares-Ayerbes, Manuel; Toledano-Fonseca, Marta; Grana, Begona; Jimenez-Fonseca, Paula; Pulido-Cortijo, Gema; Gil, Silvia; Sastre, Javier; Salud, Antonieta; Rivera, Fernando; Salgado, Mercedes; Garcia-Alfonso, Pilar; Lopez, Rafael Lopez; Guillen-Ponce, Carmen; Rodriguez-Ariza, Antonio; Vieitez, Jose Ma; Diaz-Rubio, Eduardo; Aranda, Enrique; Spanish Cooperat Grp Treatment Digest Tumours TTD
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
ESMO OPEN
IF8.3
2024-12-010
PRE
Garcia-Alfonso, P.; Elez, E.; Soto-Alsar, J.; Paez, D.; Fernandez-Montes, A.; Grana, B.; Salud, A.; Yubero, A.; Gomez-Espana, M. A.; Macias, I.; Quintero, G.; Lopez-Lopez, C.; Fernandez-Rodriguez, T.; Gravalos, C.; Gonzalez-Flores, E.; Guix, M.; Paredes, B. Garcia; Reina, J. J.; Mowbray, J. R. Rodriguez; Sastre, J.; Aranda, E.
Early carcinoembryonic antigen (CEA) dynamics to predict the efficacy of fruquintinib (F) plus best supportive care (BSC) in patients with metastatic colorectal cancer (mCRC) enrolled in FRESCO-2
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Lonardi, Sara; Dasari, Arvind; Garcia-Carbonero, Rocio; Yoshino, Takayuki; Garcia-Alfonso, Pilar; Kocsis, Judit; Cremolini, Chiara; Ghiringhelli, Francois; Shergill, Ardaman; Hochster, Howard S.; Ducreux, Michel; Arnold, Dirk; Sundaresan, Varsha; Kasar, Siddha; Pina, Adela; Yu, Ziji; Schelman, William R.; Chen, Lucy; Tabernero, Josep
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Fruquintinib与安慰剂在难治性转移性结直肠癌患者中的比较 (FRESCO-2): 一项国际，多中心，随机，双盲，3期研究

LANCET
IF88.5
2023-07-01101
PRE
Dasari, Arvind; Lonardi, Sara; Garcia-Carbonero, Rocio; Elez, Elena; Yoshino, Takayuki; Sobrero, Alberto; Yao, James; Garcia-Alfonso, Pilar; Kocsis, Judit; Gracian, Antonio Cubillo; Sartore-Bianchi, Andrea; Satoh, Taroh; Randrian, Violaine; Tomasek, Jiri; Chong, Geoff; Paulson, Andrew Scott; Masuishi, Toshiki; Jones, Jeremy; Csoszi, Tibor; Cremolini, Chiara; Ghiringhelli, Francois; Shergill, Ardaman; Hochster, Howard S.; Krauss, John; Bassam, Ali; Ducreux, Michel; Elme, Anneli; Faugeras, Laurence; Kasper, Stefan; Van Cutsem, Eric; Arnold, Dirk; Nanda, Shivani; Yang, Zhao; Schelman, William R.; Kania, Marek; Tabernero, Josep; Eng, Cathy
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNu-1 and Phase II VISNu-2 Randomized Trials
CLINICAL COLORECTAL CANCER
IF3.2
2023-06-012
PRE
Jimenez-Fonseca, P.; Sastre, J.; Garcia-Alfonso, P.; Gomez-Espana, M. A.; Salud, A.; Gil, S.; Rivera, F.; Reina, J. J.; Quintero, G.; Valladares-Ayerbes, M.; Safont, M. J.; La Casta, A.; Robles-Diaz, L.; Garcia-Paredes, B.; Lopez, R. Lopez; Guillot, M.; Gallego, J.; Alonso-Orduna, V.; Diaz-Rubio, E.; Aranda, E.
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
BIOMEDICINE & PHARMACOTHERAPY
IF7.5
2023-03-016
OAAI
Toledano-Fonseca, M.; Gomez-Espana, M. A.; Elez, E.; Gravalos, C.; Garcia-Alfonso, P.; Rodriguez, R.; Losa, F.; Diaz, I. Ales; Grana, B.; Valladares-Ayerbes, M.; Garcia-Ortiz, M. V.; Polo, E.; Salgado, M.; Rivera, F.; Safont, M. J.; Salud, A.; Ruiz-Casado, A.; Tabernero, J. M.; Riesco, M. C.; Rodriguez-Ariza, A.; Aranda, E.
FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer
ANNALS OF ONCOLOGY
IF65.4
2022-09-0127
OAAI
Dasari, N. A.; Lonardi, S.; Garcia-Carbonero, R.; Elez Fernandez, M. E.; Yoshino, T.; Sobrero, A. F.; Yao, J. C.; Garcia-Alfonso, P.; Kocsis, J.; Cubillo Gracian, A.; Sartore Bianchi, A.; Satoh, T.; Randrian, V.; Tomasek, J.; Chong, G.; Yang, Z.; Schelman, W.; Kania, M.; Tabernero, J.; Eng, C.
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
EJSO
IF2.9
2022-05-013
PRE
Benavides, Manuel; Gomez-Espana, Auxiliadora; Garcia-Alfonso, Pilar; Garcia Gonzalez, Cristina; Maria Vieitez, Jose; Rivera, Fernando; Jose Safont, Maria; Abad, Albert; Sastre, Javier; Valladares-Ayerbes, Manuel; Carrato, Alfredo; Gonzalez-Flores, Encarnacion; Robles, Luis; Salud, Antonieta; Alonso-Orduna, Vicente; Montagut, Clara; Asensio, Elena; Diaz-Rubio, Eduardo; Aranda, Enrique

研究方向

暂未获取到该数据
E
Enrique Aranda
H 指数:49论文数:513被引数:1.5万
É
Élena Elez
H 指数:58论文数:585被引数:1.9万
R
Rocio García‐Carbonero
H 指数:64论文数:595被引数:1.9万
M
Manuel Valladares‐Ayerbes
H 指数:24论文数:114被引数:1,899
C
Cristina Grávalos
H 指数:27论文数:111被引数:3,311
E
Eduardo Díaz‐Rubio
H 指数:65论文数:572被引数:2.2万
J
Javier Sastre
H 指数:49论文数:249被引数:1.0万
A
Antonieta Salud
H 指数:32论文数:201被引数:4,353
J
Josep Tabernero
H 指数:146论文数:2,711被引数:12.7万
F
Fernando Rivera
H 指数:54论文数:257被引数:2.5万